Equipo de liderazgo
Nuestro equipo ejecutivo cuenta con un grupo diverso de profesionales de la salud y la tecnología con experiencia que sirven de guía a Glooko para impulsar una innovación mayor y resultados comerciales
Russ Johannesson
Chief Executive Officer
Mark Clements, M.D., Ph.D.
Chief Medical Officer
Stephen Lien
Chief Financial Officer
Prakash Menon
Chief Technology Officer
David Conn
Executive Vice President of Partnerships & Alliances
Ed Marshall
Chief Product Officer
Adam Hameed
President of Connected Care
David Pass
President of Life Sciences
Junta Directiva
Nuestra Junta Directiva está compuesta por ejecutivos de la industria y fundadores que apoyan, asesoran y permiten que Glooko sea el líder en gestión de datos y supervisión remota de pacientes con diabetes y otras afecciones crónicas
Charles Boorady
Founder & Managing Partner, Health Catalyst Capital
Simon Chong
Co-Founder and Managing Partner, Georgian Partners
Wende Hutton
General Partner, Canaan Partners
Russ Johannesson
Chief Executive Officer, Glooko
Tracy Bahl
OneOncology, CVS, General Atlantic, Emdeon, UHG
Enrique Conterno
Former Eli Lilly & Company Senior Executive
Alfonso (Chito) Zulueta
Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company
Yogen Dalal
Founder, Glooko
Board Observer
Junta de asesoría médica
Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City
Jerome Fischer, M.D.
Partner, Diabetes and Glandular Disease (DGD) Clinic
Michael Greenfield, M.D.
Endocrinologist, El Camino Hospital
David Kerr, M.D.
Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute
